UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005560
Receipt number R000006216
Scientific Title Prevalence of stress incontinence or over active bladder in patients with pollinosis
Date of disclosure of the study information 2011/05/06
Last modified on 2019/02/08 13:10:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence of stress incontinence or over active bladder in patients with pollinosis

Acronym

Pollinosis and urinary incontinence

Scientific Title

Prevalence of stress incontinence or over active bladder in patients with pollinosis

Scientific Title:Acronym

Pollinosis and urinary incontinence

Region

Japan


Condition

Condition

Pollinosis

Classification by specialty

Clinical immunology Oto-rhino-laryngology Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is surveying the prevalence of lower urinary tract symptoms including urinary incontinence and urgency among patients with pollinosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Core Lower urinary tract Symptom Score
International Prostate Symptom Score
Overactive Bladder Symptom Score
JRQLQ

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with pollinosis

Key exclusion criteria

1 Patients with pollinosis who have already treated.
2 Patients with pollinosis who cannot receive standard treatment because of any reason

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Motofumi Suzuki

Organization

The University of Tokyo Hospital

Division name

Department of Urology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan

TEL

03-5800-8753

Email



Public contact

Name of contact person

1st name
Middle name
Last name Motofumi Suzuki

Organization

The University of Tokyo Hospital

Division name

Department of Urology

Zip code


Address

7-3-1 Hongo Bunkyo-ku, Tokyo 113-8655, Japan

TEL

03-5800-8753

Homepage URL


Email

suzukim-uro@h.u-tokyo.ac.jp


Sponsor or person

Institute

The University of Tokyo Hospital

Institute

Department

Personal name



Funding Source

Organization

The University of Tokyo Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Seirei Hamamatsu Genaral Hospital
Hamamatsu University School of Medicine

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

聖隷浜松病院(静岡県)


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 04 Month 15 Day

Date of IRB


Anticipated trial start date

2011 Year 05 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 03 Month 01 Day


Other

Other related information

1) Primary end point
Urination related questionnairs
Core Lower urinary tract Symptom Score; CLSS
International Prostate Symptom Score; IPSS
Overactive Bladder Symptom Score; OABSS
2)Secondary end point
JRQLQ


Management information

Registered date

2011 Year 05 Month 06 Day

Last modified on

2019 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006216


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name